Immuneering Corporation (IMRX)

1.48

-0.17 (-10.30%)

At close: Mar 03, 2025, 3:59 PM

1.48

0.09%

After-hours: Mar 03, 2025, 07:03 PM EST

Immuneering Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-53.47M	-50.51M	-33.54M	-17.04M	-7.71M
Depreciation & Amortization	352.08K	796.79K	159.07K	79.31K	18.08K
Stock-Based Compensation	5.73M	4.06M	1.8M	1.09M	596.63K
Other Working Capital	119.84K	-276.56K	751.1K	357.58K	-465K
Other Non-Cash Items	-601.59K	-166.21K	130.24K	349.96K	1.48M
Deferred Income Tax	n/a	n/a	-307.49K	-349.96K	739.03K
Change in Working Capital	-974.64K	1.72M	900.42K	1.25M	437.13K
Operating Cash Flow	-48.97M	-44.1M	-30.85M	-14.62M	-4.44M
Capital Expenditures	-342.75K	-742.48K	-60.79K	-53.41K	-20.53K
Acquisitions	n/a	-41.83M	70.35K	n/a	n/a
Purchase of Investments	-44.66M	-50.1M	-75.63M	n/a	n/a
Sales Maturities Of Investments	52.3M	92.68M	75.62M	n/a	n/a
Other Investing Acitivies	n/a	41.83M	-75.62M	n/a	n/a
Investing Cash Flow	7.3M	41.83M	-75.62M	-53.41K	-20.53K
Debt Repayment	n/a	n/a	n/a	n/a	3.83M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	241.07K	19K	23.95M	37.98M	9.52M
Financial Cash Flow	28.44M	19K	144.26M	37.98M	17.17M
Net Cash Flow	-13.23M	-2.25M	37.8M	23.31M	12.71M
Free Cash Flow	-49.31M	-44.84M	-30.91M	-14.67M	-4.46M